Good evening :)
Place Order
Add to Watchlist

Vijaya Diagnostic Centre Ltd

VIJAYA

Vijaya Diagnostic Centre Ltd

VIJAYA
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹10,967 cr, stock is ranked 495
Moderate RiskStock is 2.91x as volatile as Nifty
1,147.907.41% (+79.15)
1,147.907.41% (+79.15)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹10,967 cr, stock is ranked 495
Moderate RiskStock is 2.91x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹10,967 cr, stock is ranked 495
Moderate RiskStock is 2.91x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
82.7416.620.09%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
49.706.310.52%

Forecast & Ratings

Detailed Forecast 
57%
Analysts have suggested that investors can buy this stock

from 7 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Vijaya Diagnostic Centre is an India-based diagnostic network company providing professional services ranging from health checkups, home sample collection and corporate wellness.

Investor Presentation

View older 

Nov 7, 2024

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 13.42%, vs industry avg of 10.02%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.83% to 0.92%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 20.97%, vs industry avg of 42.9%

Loading...

Financial YearFY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue257.28302.95354.18388.60475.20473.37568.63643.50
Raw Materialssubtract36.5540.4843.9457.0971.5058.8865.44376.49
Power & Fuel Costsubtract8.439.2910.7210.1911.6014.8318.27
Employee Costsubtract41.9753.8862.4057.4370.6678.4890.22
Selling & Administrative Expensessubtract52.3862.5769.1058.9776.0590.44113.45
Operating & Other expensessubtract31.7118.2520.0427.0928.8734.5641.58
Depreciation/Amortizationsubtract26.2839.6349.1750.4552.6961.7257.0064.31
Interest & Other Itemssubtract5.0413.5315.3915.2516.4520.9523.9924.99
Taxes & Other Itemssubtract19.8619.4520.8927.6437.7128.8839.8545.16
EPS3.444.506.138.2910.768.3011.6312.95
DPS0.000.000.000.001.001.001.001.00
Payout ratio0.000.000.000.000.090.120.090.08

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

May 26PDF
Feb 4PDF
Nov 8PDF
FY 2023

Annual report

PDF

Investor Presentation

May 29PDF
Feb 13PDF
Nov 10PDF
Aug 9PDF
FY 2024

Annual report

PDF

Investor Presentation

Aug 9PDF
FY 2025

Annual Report Pending

Investor Presentation

Nov 7PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Vijaya Diagnostic Centre Ltd92.3016.620.09%
Max Healthcare Institute Ltd91.7011.540.15%
Apollo Hospitals Enterprise Ltd106.9913.130.24%
Fortis Healthcare Ltd82.925.800.15%

Price Comparison

Compare VIJAYA with any stock or ETF
Compare VIJAYA with any stock or ETF
VIJAYA
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Decreased Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has decreased by 1.95%

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding53.91%22.87%0.59%18.14%4.49%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep20.27%20.68%19.95%20.09%20.08%18.14%

Mutual Funds Holding Trend

Increased Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 1.97%

Top 5 Mutual Funds holding Vijaya Diagnostic Centre Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Kotak Small Cap Fund - Growth - Direct Plan

Growth
4.0043%2.50%0.52%3/83 (+11)
Nippon India Pharma Fund - Growth - Direct Plan

Growth
2.7564%3.48%0.54%8/36 (+5)
Nippon India Multi Cap Fund - Growth - Direct Plan

Growth
2.5159%0.70%0.12%42/122 (+14)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateAug 30, 2024

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Aug 30, 2024

Cash Dividend

Ex DateEx DateSep 13, 2023

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Sep 13, 2023

Cash Dividend

Ex DateEx DateSep 20, 2022

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Sep 20, 2022

News & Opinions
Corporate
Vijaya Diagnostic Centre allots 7,192 equity shares under ESOP

Vijaya Diagnostic Centre has allotted 7,192 equity shares under ESOP. Consequent to aforesaid allotment the issued, subscribed, and paid-up equity share capital of the Company has increased from Rs 10,26,22,270/- to Rs 10,26,29,462/-Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Vijaya Diagnostic Centre COO resigns

Vijaya Diagnostic Centre announced the resignation of Sheshadri Vasan from the position of Chief Operating Officer with effect from 06 November 2024. Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Earnings
Vijaya Diagnostic Centre consolidated net profit rises 25.87% in the September 2024 quarter

Net profit of Vijaya Diagnostic Centre rose 25.87% to Rs 41.94 crore in the quarter ended September 2024 as against Rs 33.32 crore during the previous quarter ended September 2023. Sales rose 31.75% to Rs 182.95 crore in the quarter ended September 2024 as against Rs 138.86 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales182.95138.86 32 OPM %41.5341.31 - PBDT74.0258.26 27 PBT57.1944.58 28 NP41.9433.32 26 Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Vijaya Diagnostic Centre schedules board meeting

Vijaya Diagnostic Centre will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Vijaya Diagnostic Centre announces resignation of COO

Vijaya Diagnostic Centre announced that Sheshadri Vasan, Chief Operating Officer of the Company has resigned from the services of the Company. His last date with the Company would be on or before 06 November 2024. Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Vijaya Diagnostic Centre AGM scheduled

Vijaya Diagnostic Centre announced that the Annual General Meeting (AGM) of the company will be held on 6 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Vijaya Diagnostic Centre consolidated net profit rises 19.66% in the June 2024 quarter

Net profit of Vijaya Diagnostic Centre rose 19.66% to Rs 31.35 crore in the quarter ended June 2024 as against Rs 26.20 crore during the previous quarter ended June 2023. Sales rose 29.05% to Rs 156.22 crore in the quarter ended June 2024 as against Rs 121.05 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales156.22121.05 29 OPM %39.2039.75 - PBDT58.5447.94 22 PBT41.9035.47 18 NP31.3526.20 20 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Vijaya Diagnostic Centre to table results

Vijaya Diagnostic Centre will hold a meeting of the Board of Directors of the Company on 5 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Seedha Sauda Stock Picks: Vijaya Diagnostic & Alembic Pharma में निवेश का यही मौका? | Business News
4 months agoCNBC Awaaz.

Board of Vijaya Diagnostic Centre approves merger with Medinova Diagnostic Services

4 months agoBusiness Standard